Structure and Functional Characterization of the RNA-Binding Element of the NLRX1 Innate Immune Modulator

Immunity

Volumn 36, Issue 3, 2012, Pages 337-347

  Hong, Minsun ^a   Yoon, Sung il ^a   Wilson, Ian A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; MITOCHONDRIAL PROTEIN; NUCLEOTIDE BINDING DOMAIN AND LEUCINE RICH REPEATCONTAINING PROTEIN 1; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; GEL FILTRATION; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; NUCLEOTIDE BINDING SITE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; RNA BINDING; RNA STRUCTURE; ULTRACENTRIFUGATION;

BINDING SITES; CRYSTALLOGRAPHY, X-RAY; HUMANS; IMMUNITY, INNATE; MITOCHONDRIAL PROTEINS; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, QUATERNARY; RECOMBINANT PROTEINS; RNA, VIRAL; RNA-BINDING PROTEINS;

EID: 84858762861     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2011.12.018     Document Type: Article

References (50)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Albrecht M., Takken F.L. Update on the domain architectures of NLRs and R proteins. Biochem. Biophys. Res. Commun. 2006, 339:459-462.
3. Allen I.C., Moore C.B., Schneider M., Lei Y., Davis B.K., Scull M.A., Gris D., Roney K.E., Zimmermann A.G., Bowzard J.B., et al. NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-κB signaling pathways. Immunity 2011, 34:854-865.
4. Arnoult D., Soares F., Tattoli I., Castanier C., Philpott D.J., Girardin S.E. An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix. J. Cell Sci. 2009, 122:3161-3168.
5. Baxter R.H., Steinert S., Chelliah Y., Volohonsky G., Levashina E.A., Deisenhofer J. A heterodimeric complex of the LRR proteins LRIM1 and APL1C regulates complement-like immunity in Anopheles gambiae. Proc. Natl. Acad. Sci. USA 2010, 107:16817-16822.
6. Bella J., Hindle K.L., McEwan P.A., Lovell S.C. The leucine-rich repeat structure. Cell. Mol. Life Sci. 2008, 65:2307-2333.
7. Beutler B., Eidenschenk C., Crozat K., Imler J.L., Takeuchi O., Hoffmann J.A., Akira S. Genetic analysis of resistance to viral infection. Nat. Rev. Immunol. 2007, 7:753-766.
8. Botos I., Segal D.M., Davies D.R. The structural biology of Toll-like receptors. Structure 2011, 19:447-459.
9. Brünger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 1998, 54:905-921.
10. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 1994, 50:760-763. Collaborative Computational Project, Number 4.
11. Cui J., Zhu L., Xia X., Wang H.Y., Legras X., Hong J., Ji J., Shen P., Zheng S., Chen Z.J., Wang R.F. NLRC5 negatively regulates the NF-κB and type I interferon signaling pathways. Cell 2010, 141:483-496.
12. Davis B.K., Roberts R.A., Huang M.T., Willingham S.B., Conti B.J., Brickey W.J., Barker B.R., Kwan M., Taxman D.J., Accavitti-Loper M.A., et al. Cutting edge: NLRC5-dependent activation of the inflammasome. J. Immunol. 2011, 186:1333-1337.
13. DeLano W.L. The PyMOL Molecular Graphics System 2002, DeLano Scientific, San Carlos, CA.
14. DeYoung B.J., Innes R.W. Plant NBS-LRR proteins in pathogen sensing and host defense. Nat. Immunol. 2006, 7:1243-1249.
15. Dieudé P., Guedj M., Wipff J., Ruiz B., Riemekasten G., Airo P., Melchers I., Hachulla E., Cerinic M.M., Diot E., et al. NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann. Rheum. Dis. 2011, 70:668-674.
16. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 2004, 60:2126-2132.
17. Evans P. Scala. Joint CCP4 and ESF-EACBM Newsletter 1997, 33:22-24.
18. Faustin B., Lartigue L., Bruey J.M., Luciano F., Sergienko E., Bailly-Maitre B., Volkmann N., Hanein D., Rouiller I., Reed J.C. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 2007, 25:713-724.
19. Franchi L., Warner N., Viani K., Nuñez G. Function of Nod-like receptors in microbial recognition and host defense. Immunol. Rev. 2009, 227:106-128.
20. Girardin S.E., Jéhanno M., Mengin-Lecreulx D., Sansonetti P.J., Alzari P.M., Philpott D.J. Identification of the critical residues involved in peptidoglycan detection by Nod1. J. Biol. Chem. 2005, 280:38648-38656.
21. Harton J.A., Linhoff M.W., Zhang J., Ting J.P. Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains. J. Immunol. 2002, 169:4088-4093.
22. Hendrickson W.A. Determination of macromolecular structures from anomalous diffraction of synchrotron radiation. Science 1991, 254:51-58.
23. Hillig R.C., Renault L., Vetter I.R., Drell T.T., Wittinghofer A., Becker J. The crystal structure of rna1p: a new fold for a GTPase-activating protein. Mol. Cell 1999, 3:781-791.
24. Huizinga E.G., Tsuji S., Romijn R.A., Schiphorst M.E., de Groot P.G., Sixma J.J., Gros P. Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Science 2002, 297:1176-1179.
25. Inohara N., Nuñez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 2003, 3:371-382.
26. Inohara N., Koseki T., del Peso L., Hu Y., Yee C., Chen S., Carrio R., Merino J., Liu D., Ni J., Núñez G. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J. Biol. Chem. 1999, 274:14560-14567.
27. Inohara N., Chamaillard M., McDonald C., Nuñez G. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu. Rev. Biochem. 2005, 74:355-383.
28. Kobe B. Crystallization and crystal structure determination of ribonuclease A-ribonuclease inhibitor protein complex. Methods Mol. Biol. 2001, 160:201-211.
29. Kobe B., Deisenhofer J. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature 1993, 366:751-756.
30. Kobe B., Deisenhofer J. A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature 1995, 374:183-186.
31. Kobe B., Deisenhofer J. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A. J. Mol. Biol. 1996, 264:1028-1043.
32. Kobe B., Kajava A.V. The leucine-rich repeat as a protein recognition motif. Curr. Opin. Struct. Biol. 2001, 11:725-732.
33. Leslie A. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 + ESF-EAMCB Newsletter on Protein Crystallography 1992, 26.
34. Liu L., Botos I., Wang Y., Leonard J.N., Shiloach J., Segal D.M., Davies D.R. Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 2008, 320:379-381.
35. Lu W.G., Zou Y.F., Feng X.L., Yuan F.L., Gu Y.L., Li X., Li C.W., Jin C., Li J.P. Association of NOD1 (CARD4) insertion/deletion polymorphism with susceptibility to IBD: a meta-analysis. World J. Gastroenterol. 2010, 16:4348-4356.
36. Lundblad J.R., Laurance M., Goodman R.H. Fluorescence polarization analysis of protein-DNA and protein-protein interactions. Mol. Endocrinol. 1996, 10:607-612.
37. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007, 449:819-826.
38. Molnar T., Hofner P., Nagy F., Lakatos P.L., Fischer S., Lakatos L., Kovacs A., Altorjay I., Papp M., Palatka K., et al. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease. Dig. Liver Dis. 2007, 39:1064-1070. Hungarian IBD Study Group.
39. Moore C.B., Bergstralh D.T., Duncan J.A., Lei Y., Morrison T.E., Zimmermann A.G., Accavitti-Loper M.A., Madden V.J., Sun L., Ye Z., et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 2008, 451:573-577.
40. Pontillo A., Vendramin A., Catamo E., Fabris A., Crovella S. The missense variation Q705K in CIAS1/NALP3/NLRP3 gene and an NLRP1 haplotype are associated with celiac disease. Am. J. Gastroenterol. 2011, 106:539-544.
41. Proell M., Riedl S.J., Fritz J.H., Rojas A.M., Schwarzenbacher R. The Nod-like receptor (NLR) family: a tale of similarities and differences. PLoS ONE 2008, 3:e2119.
42. Riedl S.J., Li W., Chao Y., Schwarzenbacher R., Shi Y. Structure of the apoptotic protease-activating factor 1 bound to ADP. Nature 2005, 434:926-933.
43. Rosenstiel P., Till A., Schreiber S. NOD-like receptors and human diseases. Microbes Infect. 2007, 9:648-657.
44. Tanabe T., Chamaillard M., Ogura Y., Zhu L., Qiu S., Masumoto J., Ghosh P., Moran A., Predergast M.M., Tromp G., et al. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J. 2004, 23:1587-1597.
45. Tattoli I., Carneiro L.A., Jéhanno M., Magalhaes J.G., Shu Y., Philpott D.J., Arnoult D., Girardin S.E. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production. EMBO Rep. 2008, 9:293-300.
46. Terwilliger T.C., Berendzen J. Automated MAD and MIR structure solution. Acta Crystallogr. D Biol. Crystallogr. 1999, 55:849-861.
47. Ting J.P., Davis B.K. CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu. Rev. Immunol. 2005, 23:387-414.
48. Vagin A.A., Steiner R.A., Lebedev A.A., Potterton L., McNicholas S., Long F., Murshudov G.N. REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use. Acta Crystallogr. D Biol. Crystallogr. 2004, 60:2184-2195.
49. Xia X., Cui J., Wang H.Y., Zhu L., Matsueda S., Wang Q., Yang X., Hong J., Songyang Z., Chen Z.J., Wang R.F. NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK. Immunity 2011, 34:843-853.
50. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 2010, 11:136-140.